Executive files Form 144 for RSU sale

The filing is a Form 144 notice reporting proposed sales of Common Stock tied to Restricted Stock Units.

Rhea-AI Filing Summary

The filing is a Form 144 notice reporting proposed sales of Common Stock tied to Restricted Stock Units. The document lists 5,394 RSUs with an effective/record date of 04/30/2026 and multiple planned or effected 10b5-1 sales by Christine Ring on dates in 02/09/2026, 03/02/2026, 04/02/2026, and 04/30/2026.

Key Figures

Form type: Form 144 RSUs listed: 5,394 shares Sale — 04/30/2026: 3,214 shares +4 more

7 metrics

Form type Form 144 notice of proposed sale

RSUs listed 5,394 shares Restricted Stock Units, 04/30/2026

Sale — 04/30/2026 3,214 shares Proceeds $53,497.99 (listed)

Sale — 04/02/2026 8,148 shares Proceeds $124,148.63 (listed)

Sale — 03/02/2026 8,148 shares Proceeds $125,792.90 (listed)

Sale — 02/09/2026 (entry 1) 8,148 shares Proceeds $135,757.90 (listed)

Sale — 02/09/2026 (entry 2) 6,113 shares Proceeds $101,860.92 (listed)

Key Terms

Restricted Stock Units, 10b5-1 Sales, Form 144

3 terms

Restricted Stock Units financial

"Restricted Stock Units | Issuer | 5394 | 04/30/2026"

Restricted stock units are a type of company reward where employees are promised shares of stock, but they only fully own these shares after meeting certain conditions, like staying with the company for a set time. They matter because they can become valuable assets and are often used to motivate employees to help the company succeed.

10b5-1 Sales regulatory

"10b5-1 Sales for CHRISTINE RING ... 04/02/2026"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

Form 144 regulatory

"Filer Information | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What does NRIX's Form 144 disclose about insider sales?

The Form 144 reports proposed sales tied to Restricted Stock Units and Rule 10b5-1 arrangements. It lists 5,394 RSUs and multiple 10b5-1 sale entries by Christine Ring on dates in Feb–Apr 2026 with specific share counts and dollar amounts.

How many RSUs are listed in the NRIX Form 144 filing?

The filing shows 5,394 Restricted Stock Units with a date reference of 04/30/2026. This figure appears in the securities-to-be-sold section and is presented as the RSU count tied to the proposed sale notice.

Who is the reporting person on the Form 144 and what sales are shown?

The reporting person is Christine Ring. The filing lists 10b5-1 sales on 02/09/2026, 03/02/2026, 04/02/2026, and 04/30/2026 with individual share counts and dollar proceeds shown for each date.

Do the Form 144 entries state the sales were made under 10b5-1 plans?

Yes. Several sale lines are labeled as 10b5-1 Sales for Christine Ring. The entries pair dates with share counts and dollar amounts, indicating the sales were associated with prearranged trading plans.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 05/01/2026 - 04:49 PM Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0001817199
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	NURIX THERAPEUTICS INC
SEC File Number	001-39398
Address of Issuer	1600 Sierra Point Parkway Brisbane CALIFORNIA 94005
Phone	4156605320
Name of Person for Whose Account the Securities are To Be Sold	CHRISTINE RING
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	5394	90079.80	103405813	05/01/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	04/30/2026	Restricted Stock Units	Issuer			5394	04/30/2026	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/30/2026	3214	53497.99
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	04/02/2026	8148	124148.63
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	03/02/2026	8148	125792.90
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	02/09/2026	8148	135757.90
10b5-1 Sales for CHRISTINE RING 1600 Sierra Point Parkway Brisbane CA 94005	Common	02/09/2026	6113	101860.92

144: Remarks and Signature

Remarks
Date of Notice	05/01/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	11/10/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Christine Ring
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)